Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02458118Phase 2Unknown
Phase 2, open-label, single-arm trial, sponsored by University of Nottingham. Primary endpoint: Blood flow to pancreas as measured by arterial spin labelling MRI at 1.5 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02458118.